These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15172047)

  • 41. Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid arthritis.
    Shergy WJ
    Semin Arthritis Rheum; 2009 Jun; 38(6):434-43. PubMed ID: 18538830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic strategies for rheumatoid arthritis.
    Smolen JS; Steiner G
    Nat Rev Drug Discov; 2003 Jun; 2(6):473-88. PubMed ID: 12776222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis.
    Massarotti EM
    Clin Ther; 2008 Mar; 30(3):429-42. PubMed ID: 18405783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 45. Orencia approved for rheumatoid arthritis.
    Health News; 2006 Mar; 12(3):2. PubMed ID: 16535763
    [No Abstract]   [Full Text] [Related]  

  • 46. [Abatacept].
    Taéron C
    Rev Infirm; 2008 May; (140):47-9. PubMed ID: 18561862
    [No Abstract]   [Full Text] [Related]  

  • 47. One more rheumatoid drug.
    Health News; 2004 Jan; 10(1):8. PubMed ID: 15002381
    [No Abstract]   [Full Text] [Related]  

  • 48. A signal achievement in the treatment of arthritis.
    Cron RQ
    Arthritis Rheum; 2005 Aug; 52(8):2229-32. PubMed ID: 16052533
    [No Abstract]   [Full Text] [Related]  

  • 49. The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis.
    Emery P
    Expert Opin Investig Drugs; 2003 Apr; 12(4):673-81. PubMed ID: 12665422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis.
    Cutolo M; Nadler SG
    Autoimmun Rev; 2013 May; 12(7):758-67. PubMed ID: 23340277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination biologic therapy.
    Isaacs JD; Morgan AW; Strand V
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S121-4. PubMed ID: 10589370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Make or break for costimulatory blockers.
    Garber K
    Nat Biotechnol; 2004 Feb; 22(2):145-7. PubMed ID: 14755280
    [No Abstract]   [Full Text] [Related]  

  • 53. Remission of rheumatoid arthritis on brentuximab vedotin.
    Vachhani P; Bose N; Brodeur JP; Holkova B; Bose P
    Rheumatology (Oxford); 2014 Dec; 53(12):2314-5. PubMed ID: 25239883
    [No Abstract]   [Full Text] [Related]  

  • 54. [Osteoimmunology-IMMUNOBONE : Regulation of bone by inflammation].
    Rauner M; Buttgereit F; Distler J; Garbe AI; Herrmann M; Hofbauer L; Hoffmann M; Jessberger R; Kornak U; Krönke G; Mundlos S; Spies C; Tuckermann J; Zwerina J
    Z Rheumatol; 2018 May; 77(Suppl 1):12-15. PubMed ID: 29691689
    [No Abstract]   [Full Text] [Related]  

  • 55. A new century of antirheumatic therapy.
    McMurray RW
    Am J Med Sci; 2002 Apr; 323(4):169-70. PubMed ID: 12003370
    [No Abstract]   [Full Text] [Related]  

  • 56. Screening for antirheumatic activity.
    Hunneyball IM
    Agents Actions Suppl; 1988; 24():19-30. PubMed ID: 3263757
    [No Abstract]   [Full Text] [Related]  

  • 57. The innate immune system in rheumatoid arthritis.
    Arend WP
    Arthritis Rheum; 2001 Oct; 44(10):2224-34. PubMed ID: 11665962
    [No Abstract]   [Full Text] [Related]  

  • 58. 7th Interscience World Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators. Geneva, Switzerland, 19-21 May 1997. Abstracts.
    Int J Tissue React; 1997; 19(1-2):17-128. PubMed ID: 9253424
    [No Abstract]   [Full Text] [Related]  

  • 59. Juvenile Idiopathic Arthritis: Diagnosis and Treatment.
    Giancane G; Consolaro A; Lanni S; Davì S; Schiappapietra B; Ravelli A
    Rheumatol Ther; 2016 Dec; 3(2):187-207. PubMed ID: 27747582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy].
    Feist E; Dörner T
    Z Rheumatol; 2013 Feb; 72(1):49-58. PubMed ID: 23223871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.